MoneyWorks4Me

Lyka Labs informs about change in time of board meeting

14 May 2024 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to its prior intimations dated 10th May 2024, relating to the Board Meeting scheduled on Tuesday, 21st May 2024, Lyka Labs has informed that the said meeting is rescheduled at 03:30 pm instead of 12:00 noon, to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on 31st March 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1849.10
Dr. Reddys Labs. 1200.95
Cipla 1399.40
Lupin 2095.80
Zydus Lifesciences 1187.00
View more..